232 related articles for article (PubMed ID: 32081544)
1. Endocrine disruptors and thyroid autoimmunity.
Benvenga S; Elia G; Ragusa F; Paparo SR; Sturniolo MM; Ferrari SM; Antonelli A; Fallahi P
Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101377. PubMed ID: 32081544
[TBL] [Abstract][Full Text] [Related]
2. Thyroid autoimmunity.
Orgiazzi J
Presse Med; 2012 Dec; 41(12 P 2):e611-25. PubMed ID: 23164679
[TBL] [Abstract][Full Text] [Related]
3. [Thyroid autoimmunity].
Orgiazzi J
Bull Acad Natl Med; 2013 Jan; 197(1):43-59; discussion 60-3. PubMed ID: 24672979
[TBL] [Abstract][Full Text] [Related]
4. A randomized-controlled, double-blind study of the impact of selenium supplementation on thyroid autoimmunity and inflammation with focus on the GPx1 genotypes.
de Farias CR; Cardoso BR; de Oliveira GM; de Mello Guazzelli IC; Catarino RM; Chammas MC; Cozzolino SM; Knobel M
J Endocrinol Invest; 2015 Oct; 38(10):1065-74. PubMed ID: 25894865
[TBL] [Abstract][Full Text] [Related]
5. Selenium and Iodine in Autoimmune Thyroiditis.
Guastamacchia E; Giagulli VA; Licchelli B; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2015; 15(4):288-92. PubMed ID: 26088475
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Selenomethionine on Thyroid Autoimmunity in Euthyroid Men With Hashimoto Thyroiditis and Testosterone Deficiency.
Krysiak R; Kowalcze K; Okopień B
J Clin Pharmacol; 2019 Nov; 59(11):1477-1484. PubMed ID: 31106856
[TBL] [Abstract][Full Text] [Related]
7. Myo-inositol and selenium reduce the risk of developing overt hypothyroidism in patients with autoimmune thyroiditis.
Ferrari SM; Fallahi P; Di Bari F; Vita R; Benvenga S; Antonelli A
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):36-42. PubMed ID: 28724175
[TBL] [Abstract][Full Text] [Related]
8. Environmental Issues in Thyroid Diseases.
Ferrari SM; Fallahi P; Antonelli A; Benvenga S
Front Endocrinol (Lausanne); 2017; 8():50. PubMed ID: 28373861
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.
Álvarez-Sierra D; Marín-Sánchez A; Ruiz-Blázquez P; de Jesús Gil C; Iglesias-Felip C; González Ó; Casteras A; Costa RF; Nuciforo P; Colobran R; Pujol-Borrell R
J Autoimmun; 2019 Sep; 103():102285. PubMed ID: 31182340
[TBL] [Abstract][Full Text] [Related]
10. Proteasome subunits, low-molecular-mass polypeptides 2 and 7 are hyperexpressed by target cells in autoimmune thyroid disease but not in insulin-dependent diabetes mellitus: implications for autoimmunity.
Vives-Pi M; Vargas F; James RF; Trowsdale J; Costa M; Sospedra M; Somoza N; Obiols G; Tampé R; Pujol-Borrell R
Tissue Antigens; 1997 Aug; 50(2):153-63. PubMed ID: 9271825
[TBL] [Abstract][Full Text] [Related]
11. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
12. Occupational exposure to ionizing radiation is associated with autoimmune thyroid disease.
Völzke H; Werner A; Wallaschofski H; Friedrich N; Robinson DM; Kindler S; Kraft M; John U; Hoffmann W
J Clin Endocrinol Metab; 2005 Aug; 90(8):4587-92. PubMed ID: 15886237
[TBL] [Abstract][Full Text] [Related]
13. The incidence and prevalence of thyroid autoimmunity.
McLeod DS; Cooper DS
Endocrine; 2012 Oct; 42(2):252-65. PubMed ID: 22644837
[TBL] [Abstract][Full Text] [Related]
14. Demographic and clinical features of autoimmune thyroid disorder in Japanese patients with systemic sclerosis.
Toki S; Motegi S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2014 Dec; 41(12):1053-7. PubMed ID: 25387898
[TBL] [Abstract][Full Text] [Related]
15. Thyroid volume, iodine intake, autoimmune thyroid disorders, inborn factors, and endocrine disruptors: twenty-year studies of multiple effects puzzle in Slovakia.
Langer P; Tajtakova M; Kocan A; Drobna B; Kostalova L; Fodor G; Klimes I
Endocr Regul; 2012 Oct; 46(4):191-203. PubMed ID: 23127503
[TBL] [Abstract][Full Text] [Related]
16. The impacts of organochlorines and other persistent pollutants on thyroid and metabolic health.
Langer P
Front Neuroendocrinol; 2010 Oct; 31(4):497-518. PubMed ID: 20797403
[TBL] [Abstract][Full Text] [Related]
17. The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases.
Fallahi P; Elia G; Ragusa F; Ruffilli I; Camastra S; Giusti C; Paparo SR; Gonnella D; Shoenfeld Y; Ferrari SM; Antonelli A
Best Pract Res Clin Endocrinol Metab; 2019 Dec; 33(6):101372. PubMed ID: 31932147
[TBL] [Abstract][Full Text] [Related]
18. [Thyroid disruptors and their consequences on brain development and behavior].
Fini JB; Demeneix B
Biol Aujourdhui; 2019; 213(1-2):17-26. PubMed ID: 31274099
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of autoimmune thyroid diseases].
Sgarbi JA; Maciel RM
Arq Bras Endocrinol Metabol; 2009 Feb; 53(1):5-14. PubMed ID: 19347180
[TBL] [Abstract][Full Text] [Related]
20. Thyroid nodules and thyroid autoimmunity in the context of environmental pollution.
Benvenga S; Antonelli A; Vita R
Rev Endocr Metab Disord; 2015 Dec; 16(4):319-40. PubMed ID: 26825072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
